Treatment of squamous cell carcinoma of the anus, unresolved areas and future perspectives for research: Perspectives of research needs in anal cancer
出版年份 2021 全文链接
标题
Treatment of squamous cell carcinoma of the anus, unresolved areas and future perspectives for research: Perspectives of research needs in anal cancer
作者
关键词
Anal Cancer, Radiotherapy, Chemotherapy, Human Papilloma Virus, Immune Checkpoint Inhibition
出版物
Clinical Colorectal Cancer
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-09-15
DOI
10.1016/j.clcc.2021.09.006
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Prognostic Value of the New Combined Hemo-Eosinophil Inflammation Index (HEI Index): A Multicenter Analysis of Anal Cancer Patients Treated with Concurrent Chemo-Radiation
- (2021) Margherita Rimini et al. Cancers
- Treatment outcomes and prognostic factors after chemoradiotherapy for anal cancer
- (2021) Kathinka S. Slørdahl et al. ACTA ONCOLOGICA
- Nonplatinum‐based therapy with Paclitaxel and Capecitabine for advanced squamous cell carcinomas of the anal canal: A population‐based Danish anal cancer group study
- (2021) Christina Glismand Truelsen et al. Cancer Medicine
- The Clinical Value of Measuring Circulating HPV DNA during Chemo-Radiotherapy in Squamous Cell Carcinoma of the Anus
- (2021) Anna C. Lefèvre et al. Cancers
- Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
- (2021) S. Rao et al. ANNALS OF ONCOLOGY
- Predicting outcomes in anal cancer patients using multi-centre data and distributed learning – A proof-of-concept study
- (2021) Ananya Choudhury et al. RADIOTHERAPY AND ONCOLOGY
- Temporal improvements in loco-regional failure and survival in patients with anal cancer treated with chemo-radiotherapy: treatment cohort study (1990–2014)
- (2020) Hema Sekhar et al. BRITISH JOURNAL OF CANCER
- Atezolizumab plus modified docetaxel-cisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: a randomized, non-comparative phase II SCARCE GERCOR trial
- (2020) Stefano Kim et al. BMC CANCER
- UK national cohort of anal cancer treated with intensity-modulated radiotherapy: One-year oncological and patient-reported outcomes
- (2020) A. Gilbert et al. EUROPEAN JOURNAL OF CANCER
- Patterns of recurrence in anal cancer: a detailed analysis
- (2020) Martin P. Nilsson et al. Radiation Oncology
- Feasibility and Outcome of Routine Use of Concurrent Chemoradiation in HIV-positive Patients With Squamous Cell Anal Cancer
- (2020) Andrew J. Leiker et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Outcome following local excision of T1 anal cancers—a systematic review
- (2020) T. B. Pedersen et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct
- (2020) Sheela Rao et al. JOURNAL OF CLINICAL ONCOLOGY
- Patterns of inguinal lymph node metastases in anal canal cancer and recommendations for elective clinical target volume (CTV) delineation
- (2020) Allison E. Garda et al. RADIOTHERAPY AND ONCOLOGY
- Role of metastasectomy for liver metastasis in stage IV anal cancer
- (2020) Matthew Goldner et al. AMERICAN JOURNAL OF SURGERY
- LBA42 POD1UM-202: Phase II study of retifanlimab in patients (pts) with squamous carcinoma of the anal canal (SCAC) who progressed following platinum-based chemotherapy
- (2020) S. Rao et al. ANNALS OF ONCOLOGY
- Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study
- (2020) Aurélien Marabelle et al. LANCET ONCOLOGY
- HPV Vaccination and the Risk of Invasive Cervical Cancer
- (2020) Jiayao Lei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Measurement of circulating free DNA in squamous cell carcinoma of the anus and relation to risk factors and recurrence
- (2020) Anna Cecilie Lefèvre et al. RADIOTHERAPY AND ONCOLOGY
- Multimodality treatment of oligometastatic anal squamous cell carcinoma: A case series and literature review
- (2019) Francesco Sclafani et al. JOURNAL OF SURGICAL ONCOLOGY
- Early stage anal margin cancer: towards evidence-based management
- (2019) Andrew G Renehan et al. Colorectal Disease
- Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier)
- (2019) Andrea Casadei-Gardini et al. Cancer Management and Research
- Anal squamous cell carcinoma – State of the art management and future perspectives
- (2018) Daniel Martin et al. CANCER TREATMENT REVIEWS
- Extended-Field Chemoradiation Therapy for Definitive Treatment of Anal Canal Squamous Cell Carcinoma Involving the Para-Aortic Lymph Nodes
- (2018) Emma B. Holliday et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Toxicity, Tolerability, and Compliance of Concurrent Capecitabine or 5-Fluorouracil in Radical Management of Anal Cancer With Single-dose Mitomycin-C and Intensity Modulated Radiation Therapy: Evaluation of a National Cohort
- (2018) Christopher M. Jones et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Anal Cancer Risk Among People With HIV Infection in the United States
- (2018) Vivian Colón-López et al. JOURNAL OF CLINICAL ONCOLOGY
- Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
- (2018) Al B. Benson et al. Journal of the National Comprehensive Cancer Network
- Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study
- (2018) Stefano Kim et al. LANCET ONCOLOGY
- Phase I–III development of the EORTC QLQ-ANL27, a health-related quality of life questionnaire for anal cancer
- (2018) Samantha C. Sodergren et al. RADIOTHERAPY AND ONCOLOGY
- Prospective evaluation of acute toxicity and patient reported outcomes in anal cancer and plan optimization
- (2018) Camilla Kronborg et al. RADIOTHERAPY AND ONCOLOGY
- Determinants for local tumour control probability after radiotherapy of anal cancer
- (2018) Anders Johnsson et al. RADIOTHERAPY AND ONCOLOGY
- Systemic Therapies for Advanced Squamous Cell Anal Cancer
- (2018) Francesco Sclafani et al. Current Oncology Reports
- Comparing simultaneous integrated boost vs sequential boost in anal cancer patients: results of a retrospective observational study
- (2018) Pierfrancesco Franco et al. Radiation Oncology
- Clinical validity of HPV circulating tumor DNA in advanced anal carcinoma: an ancillary study to the Epitopes-HPV02 trial
- (2018) Alice Bernard-Tessier et al. CLINICAL CANCER RESEARCH
- Rising Incidence and Improved Survival of Anal Squamous Cell Carcinoma in Norway, 1987-2016
- (2018) Marianne Grønlie Guren et al. Clinical Colorectal Cancer
- Is There a Role for an 18F-fluorodeoxyglucose-derived Biological Boost in Squamous Cell Anal Cancer?
- (2018) A. Sabbagh et al. CLINICAL ONCOLOGY
- Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial
- (2017) Robert Glynne-Jones et al. LANCET ONCOLOGY
- Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study
- (2017) Van K Morris et al. LANCET ONCOLOGY
- External validation of leukocytosis and neutrophilia as a prognostic marker in anal carcinoma treated with definitive chemoradiation
- (2017) Antoine Schernberg et al. RADIOTHERAPY AND ONCOLOGY
- Leukocytosis and neutrophilia predicts outcome in anal cancer
- (2017) Antoine Schernberg et al. RADIOTHERAPY AND ONCOLOGY
- Diagnosis and Diagnostic Imaging of Anal Canal Cancer
- (2017) Kristen K. Ciombor et al. Surgical Oncology Clinics of North America
- Human papilloma virus load and PD-1/PD-L1, CD8+ and FOXP3 in anal cancer patients treated with chemoradiotherapy: Rationale for immunotherapy
- (2017) Panagiotis Balermpas et al. OncoImmunology
- Tumour-infiltrating lymphocyte scores effectively stratify outcomes over and above p16 post chemo-radiotherapy in anal cancer
- (2016) Duncan C Gilbert et al. BRITISH JOURNAL OF CANCER
- Biomarkers in anal cancer: from biological understanding to stratified treatment
- (2016) Christopher M Jones et al. BRITISH JOURNAL OF CANCER
- Trends of incidence and survival in squamous-cell carcinoma of the anal canal in France
- (2016) Anne-Marie Bouvier et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- The assessment of local response using magnetic resonance imaging at 3- and 6-month post chemoradiotherapy in patients with anal cancer
- (2016) Rohit Kochhar et al. EUROPEAN RADIOLOGY
- The Role of FDG-PET in the Initial Staging and Response Assessment of Anal Cancer: A Systematic Review and Meta-analysis
- (2015) Michael Jones et al. ANNALS OF SURGICAL ONCOLOGY
- HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53
- (2015) D Meulendijks et al. BRITISH JOURNAL OF CANCER
- Phase I study of cetuximab in combination with 5-fluorouracil, mitomycin C and radiotherapy in patients with locally advanced anal cancer
- (2015) Otilia Leon et al. EUROPEAN JOURNAL OF CANCER
- Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative
- (2015) Jan Bogaerts et al. EUROPEAN JOURNAL OF CANCER
- Molecular biology of anal squamous cell carcinoma: implications for future research and clinical intervention
- (2015) Maria-Pia Bernardi et al. LANCET ONCOLOGY
- Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: Long-term results of the UNICANCER ACCORD 16 phase II trial
- (2015) Antonin Levy et al. RADIOTHERAPY AND ONCOLOGY
- A tumor control probability model for anal squamous cell carcinoma
- (2015) Rebecca Muirhead et al. RADIOTHERAPY AND ONCOLOGY
- Systematic review of the quality of life issues associated with anal cancer and its treatment with radiochemotherapy
- (2015) Samantha C. Sodergren et al. SUPPORTIVE CARE IN CANCER
- The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canal
- (2015) Cathy Eng et al. Oncotarget
- Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option
- (2014) D Meulendijks et al. BRITISH JOURNAL OF CANCER
- The rising incidence of anal cancer in England 1990-2010: a population-based study
- (2014) J. R. Wilkinson et al. Colorectal Disease
- Long-term Effects of Chemoradiotherapy for Anal Cancer in Patients With HIV Infection
- (2014) Ingeborg B. Fraunholz et al. DISEASES OF THE COLON & RECTUM
- Human papillomavirus DNA load and p16INK4aexpression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy
- (2014) Franz Rödel et al. INTERNATIONAL JOURNAL OF CANCER
- Human Papillomavirus Genotyping and p16 Expression As Prognostic Factors for Patients With American Joint Committee on Cancer Stages I to III Carcinoma of the Anal Canal
- (2014) Eva Serup-Hansen et al. JOURNAL OF CLINICAL ONCOLOGY
- Anal carcinoma – Survival and recurrence in a large cohort of patients treated according to Nordic guidelines
- (2014) Otilia Leon et al. RADIOTHERAPY AND ONCOLOGY
- Anal cancer: ESMO–ESSO–ESTRO clinical practice guidelines for diagnosis, treatment and follow-up
- (2014) Robert Glynne-Jones et al. RADIOTHERAPY AND ONCOLOGY
- Impaired health-related quality of life after chemoradiotherapy for anal cancer: Late effects in a national cohort of 128 survivors
- (2013) Anne Gry Bentzen et al. ACTA ONCOLOGICA
- Squamous cell carcinoma antigen
- (2013) Matt Williams et al. CANCER
- Phase 1 study of cetuximab in combination with 5-fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinoma
- (2013) Luis O. Olivatto et al. CANCER
- Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus
- (2013) E. Toh et al. Colorectal Disease
- Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2×2 factorial trial
- (2013) Roger D James et al. LANCET ONCOLOGY
- p16INK4A, p53, EGFR expression and KRAS mutation status in squamous cell cancers of the anus: Correlation with outcomes following chemo-radiotherapy
- (2013) Duncan C Gilbert et al. RADIOTHERAPY AND ONCOLOGY
- Faecal incontinence after chemoradiotherapy in anal cancer survivors: Long-term results of a national cohort
- (2013) Anne Gry Bentzen et al. RADIOTHERAPY AND ONCOLOGY
- EGFR and K-ras gene mutation status in squamous cell anal carcinoma: a role for concurrent radiation and EGFR inhibitors?
- (2012) A Paliga et al. BRITISH JOURNAL OF CANCER
- Australasian Gastrointestinal Trials Group (AGITG) Contouring Atlas and Planning Guidelines for Intensity-Modulated Radiotherapy in Anal Cancer
- (2012) Michael Ng et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Carcinoma of the Anal Canal
- (2012) Lisa A. Kachnic et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Induction Chemotherapy and Dose Intensification of the Radiation Boost in Locally Advanced Anal Canal Carcinoma: Final Analysis of the Randomized UNICANCER ACCORD 03 Trial
- (2012) Didier Peiffert et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)
- (2010) J Northover et al. BRITISH JOURNAL OF CANCER
- Prognostic biomarkers in squamous cell carcinoma of the anus: a systematic review
- (2010) T Lampejo et al. BRITISH JOURNAL OF CANCER
- Dose-Painted Intensity-Modulated Radiation Therapy for Anal Cancer: A Multi-Institutional Report of Acute Toxicity and Response to Therapy
- (2010) Lisa A. Kachnic et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- The Missing Voice of Patients in Drug-Safety Reporting
- (2010) Ethan Basch NEW ENGLAND JOURNAL OF MEDICINE
- Long-term quality of life after radiotherapy for the treatment of anal cancer
- (2009) Prajnan Das et al. CANCER
- Immunosuppressive disorders and risk of anal squamous cell carcinoma: A nationwide cohort study in Denmark, 1978-2005
- (2009) Kåre G. Sunesen et al. INTERNATIONAL JOURNAL OF CANCER
- Intensity-Modulated Radiation Therapy for the Treatment of Squamous Cell Anal Cancer With Para-aortic Nodal Involvement
- (2009) Joseph C. Hodges et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- EXTRA—A Multicenter Phase II Study of Chemoradiation Using a 5 Day per Week Oral Regimen of Capecitabine and Intravenous Mitomycin C in Anal Cancer
- (2008) Rob Glynne-Jones et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Elective Clinical Target Volumes for Conformal Therapy in Anorectal Cancer: A Radiation Therapy Oncology Group Consensus Panel Contouring Atlas
- (2008) Robert J. Myerson et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Fluorouracil, Mitomycin, and Radiotherapy vs Fluorouracil, Cisplatin, and Radiotherapy for Carcinoma of the Anal Canal
- (2008) Jaffer A. Ajani JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started